Sahib Singh, Udaya S Tantry, Kevin Bliden, Marwan Saad, Paul A Gurbel, J Dawn Abbott, Aakash Garg
{"title":"心肌梗死中生理指导下完全或仅病灶经皮冠状动脉介入治疗的 Meta 分析。","authors":"Sahib Singh, Udaya S Tantry, Kevin Bliden, Marwan Saad, Paul A Gurbel, J Dawn Abbott, Aakash Garg","doi":"10.1016/j.amjcard.2024.09.013","DOIUrl":null,"url":null,"abstract":"<p><p>Whether a physiology-guided complete revascularization of non-culprit lesions is superior to culprit lesion-only percutaneous coronary intervention (PCI) in patients with myocardial infarction (MI) and multivessel disease (MVD) remains debated. Online databases were searched for randomized controlled trials (RCTs) comparing physiology-guided complete revascularization and culprit lesion-only PCI in MI patients. The outcomes of interest were all-cause death, cardiovascular (CV) death, repeat revascularization, MI, stent thrombosis and contrast associated nephropathy/acute kidney injury (AKI). Pooled odds ratios (OR) along with 95% confidence intervals (CI) were calculated. A total of 4,849 patients (n = 2,288 physiology-guided complete revascularization, n = 2,561 culprit lesion-only PCI) were included. Mean age was 66 years and 76% were men. At mean follow-up of 2.5 years, physiology-guided complete revascularization was associated with significant reductions in CV death (OR 0.72, 95% CI 0.54-0.97, p = 0.03) and repeat revascularizations (0.50, 95% CI 0.38-0.66, p < 0.00001) as compared to culprit lesion-only PCI. There were no differences between the two approaches in all-cause death (0.91, 95% CI 0.69-1.19, p = 0.50), MI (0.85, 95% CI 0.59-1.21, p = 0.36), stent thrombosis (1.24, 95% CI 0.58-2.69, p = 0.58) and contrast associated nephropathy/AKI (1.07, 95% CI 0.88-1.31, p = 0.50). In conclusion, among patients with MI and MVD, physiology-guided complete revascularization was associated with significant reductions in CV death and revascularizations when compared to culprit lesion-only PCI.</p>","PeriodicalId":7705,"journal":{"name":"American Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Meta-analysis of Physiology-guided Complete or Culprit lesion-only Percutaneous Coronary Interventions in Myocardial Infarction.\",\"authors\":\"Sahib Singh, Udaya S Tantry, Kevin Bliden, Marwan Saad, Paul A Gurbel, J Dawn Abbott, Aakash Garg\",\"doi\":\"10.1016/j.amjcard.2024.09.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Whether a physiology-guided complete revascularization of non-culprit lesions is superior to culprit lesion-only percutaneous coronary intervention (PCI) in patients with myocardial infarction (MI) and multivessel disease (MVD) remains debated. Online databases were searched for randomized controlled trials (RCTs) comparing physiology-guided complete revascularization and culprit lesion-only PCI in MI patients. The outcomes of interest were all-cause death, cardiovascular (CV) death, repeat revascularization, MI, stent thrombosis and contrast associated nephropathy/acute kidney injury (AKI). Pooled odds ratios (OR) along with 95% confidence intervals (CI) were calculated. A total of 4,849 patients (n = 2,288 physiology-guided complete revascularization, n = 2,561 culprit lesion-only PCI) were included. Mean age was 66 years and 76% were men. At mean follow-up of 2.5 years, physiology-guided complete revascularization was associated with significant reductions in CV death (OR 0.72, 95% CI 0.54-0.97, p = 0.03) and repeat revascularizations (0.50, 95% CI 0.38-0.66, p < 0.00001) as compared to culprit lesion-only PCI. There were no differences between the two approaches in all-cause death (0.91, 95% CI 0.69-1.19, p = 0.50), MI (0.85, 95% CI 0.59-1.21, p = 0.36), stent thrombosis (1.24, 95% CI 0.58-2.69, p = 0.58) and contrast associated nephropathy/AKI (1.07, 95% CI 0.88-1.31, p = 0.50). In conclusion, among patients with MI and MVD, physiology-guided complete revascularization was associated with significant reductions in CV death and revascularizations when compared to culprit lesion-only PCI.</p>\",\"PeriodicalId\":7705,\"journal\":{\"name\":\"American Journal of Cardiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.amjcard.2024.09.013\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjcard.2024.09.013","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
在心肌梗死(MI)和多血管疾病(MVD)患者中,生理引导下的非病灶完全血管再通是否优于单纯病灶经皮冠状动脉介入治疗(PCI)仍存在争议。我们在在线数据库中搜索了对心肌梗死患者进行生理学指导下完全血管再通和仅对病灶进行经皮冠状动脉介入治疗进行比较的随机对照试验(RCT)。研究结果包括全因死亡、心血管(CV)死亡、重复血管再通、心肌梗死、支架血栓和造影剂相关肾病/急性肾损伤(AKI)。计算了汇总的几率比(OR)和 95% 的置信区间(CI)。共纳入 4849 名患者(n = 2288 例生理引导下完全血管再通术,n = 2561 例单纯罪魁祸首病变 PCI)。平均年龄为66岁,76%为男性。在平均 2.5 年的随访中,与单纯死因病变 PCI 相比,生理学指导下的完全血运重建可显著降低 CV 死亡(OR 0.72,95% CI 0.54-0.97,p = 0.03)和重复血运重建(0.50,95% CI 0.38-0.66,p < 0.00001)。两种方法在全因死亡(0.91,95% CI 0.69-1.19,p = 0.50)、心肌梗死(0.85,95% CI 0.59-1.21,p = 0.36)、支架血栓形成(1.24,95% CI 0.58-2.69,p = 0.58)和造影剂相关肾病/AKI(1.07,95% CI 0.88-1.31,p = 0.50)方面没有差异。总之,与单纯罪魁祸首病变 PCI 相比,在心肌梗死和 MVD 患者中,生理学指导下的完全血运重建可显著降低 CV 死亡和血运重建率。
Meta-analysis of Physiology-guided Complete or Culprit lesion-only Percutaneous Coronary Interventions in Myocardial Infarction.
Whether a physiology-guided complete revascularization of non-culprit lesions is superior to culprit lesion-only percutaneous coronary intervention (PCI) in patients with myocardial infarction (MI) and multivessel disease (MVD) remains debated. Online databases were searched for randomized controlled trials (RCTs) comparing physiology-guided complete revascularization and culprit lesion-only PCI in MI patients. The outcomes of interest were all-cause death, cardiovascular (CV) death, repeat revascularization, MI, stent thrombosis and contrast associated nephropathy/acute kidney injury (AKI). Pooled odds ratios (OR) along with 95% confidence intervals (CI) were calculated. A total of 4,849 patients (n = 2,288 physiology-guided complete revascularization, n = 2,561 culprit lesion-only PCI) were included. Mean age was 66 years and 76% were men. At mean follow-up of 2.5 years, physiology-guided complete revascularization was associated with significant reductions in CV death (OR 0.72, 95% CI 0.54-0.97, p = 0.03) and repeat revascularizations (0.50, 95% CI 0.38-0.66, p < 0.00001) as compared to culprit lesion-only PCI. There were no differences between the two approaches in all-cause death (0.91, 95% CI 0.69-1.19, p = 0.50), MI (0.85, 95% CI 0.59-1.21, p = 0.36), stent thrombosis (1.24, 95% CI 0.58-2.69, p = 0.58) and contrast associated nephropathy/AKI (1.07, 95% CI 0.88-1.31, p = 0.50). In conclusion, among patients with MI and MVD, physiology-guided complete revascularization was associated with significant reductions in CV death and revascularizations when compared to culprit lesion-only PCI.
期刊介绍:
Published 24 times a year, The American Journal of Cardiology® is an independent journal designed for cardiovascular disease specialists and internists with a subspecialty in cardiology throughout the world. AJC is an independent, scientific, peer-reviewed journal of original articles that focus on the practical, clinical approach to the diagnosis and treatment of cardiovascular disease. AJC has one of the fastest acceptance to publication times in Cardiology. Features report on systemic hypertension, methodology, drugs, pacing, arrhythmia, preventive cardiology, congestive heart failure, valvular heart disease, congenital heart disease, and cardiomyopathy. Also included are editorials, readers'' comments, and symposia.